Graham Capital Management’s Agilon Health AGL Stock Holding History

Graham Capital Management’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,112	Closed	-$36.4K	–	1130
2025 Q4	$36.4K	Sell	2,112 -11,007	-84%	-$213K	﹤0.01%	1181
2025 Q3	$338K	Buy	13,119 +9,533	+266%	+$360K	0.01%	806
2025 Q2	$206K	Buy	+3,586	New	+$288K	﹤0.01%	1125
2024 Q1	–	Sell	-4,016	Closed	-$1.26M	–	1038
2023 Q4	$1.26M	Buy	+4,016	New	+$1.45M	0.03%	323

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Graham Capital Management's AGL Position: Q1 2026 in Review

Graham Capital Management sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 2,112 shares — an estimated $36.4K sold.

Graham Capital Management first reported a position in AGL in Q4 2023 and held it in 4 quarters. The position peaked at $1.26M in Q4 2023. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

Graham Capital Management reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
Graham Capital Management sold 2,112 Agilon Health shares in Q1 2026, an estimated $36.4K.
Graham Capital Management first reported a position in Agilon Health in Q4 2023 and held it in 4 quarters.
Graham Capital Management's Agilon Health position peaked at $1.26M in Q4 2023.
97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.